An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of Two Controlled Release Pregabalin Tablets As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule In Healthy Volunteers

NCT01220219 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Pregabalin controlled release, 82.5 mg
DRUG: Pregabalin controlled release, 165 mg
DRUG: Pregabalin immediate release, 75mg

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.